Gene expression markers for prediction of patient response to chemotherapy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8632980
APP PUB NO 20120040842A1
SERIAL NO

13278934

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to gene sets useful in assessing prognosis and/or predicting the response of cancer, e.g. colorectal cancer to chemotherapy. In addition, the invention relates to a clinically validated cancer test, e.g. colorectal test, for assessment of prognosis and/or prediction of patient response to chemotherapy, using expression analysis. The present invention accommodates the use of archived paraffin embedded biopsy material for assay of all markers in the relevant gene sets and therefore is compatible with the most widely available type of biopsy material.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GENOMIC HEALTH INCREDWOOD CITY CA

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Baker, Joffre B Montara, US 80 1605
Cowens, Wayne Tiburon, US 24 339
Hackett, James San Jose, US 22 329
Langone, Kim Sunnyvale, US 4 106
Paik, Soonmyung Pittsburgh, US 36 780
Watson, Drew Los Altos, US 18 291

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation